Home | My Account | Online Store | Contact & Demand | Press Room | About Us | FAQs
Home
Buy & Subscribe
Special Features
Products & Services
Online Store
Products by category
Products by publisher
Product lines
News Channels
Biotechnology
Therapeutic Areas
Business
RSS Feeds
Free RSS News
Get the latest news direct
to your desktop
feed image

Search in our News Channels

  

Search in our Online Store
DNA, RNA & Cells
Filter     Order     Display # 
Date Item Title
20 Nov 2007 Covalon Achieves Important Milestone in Its Cell-Based Gene Therapy for Treating Congestive Heart Failure and Tissue Regeneration
19 Nov 2007 Quark Announces First Systemic siRNA Dosing
19 Nov 2007 Meyer Pharmaceuticals acquires NF-kappa b decoy technology for treatment of inflammatory disease
15 Nov 2007 Thallion Announces Positive Safety and Efficacy Data From ECO-4601 Phase I/II Trial
15 Nov 2007 Athersys IND for MultiStem Authorized for Phase I Clinical Trial in Bone Marrow Transplant Support
14 Nov 2007 Invitrogen and CytRx Subsidiary RXi Pharmaceuticals Collaborate to Enhance RNAi Technologies for Therapeutic Applications
14 Nov 2007 Cardium Initiates Phase 2b Excellarate Clinical Study for Diabetic Ulcers
14 Nov 2007 Rosetta Genomics Announces Initiation of In Vivo Studies Following Successful Completion of First Milestone in MicroRNA-based Therapeutic Program for Liver Cancer
13 Nov 2007 Isis Reports New Data for Mipomersen in Routine High Cholesterol Patients and Provides Cumulative Safety Summary
13 Nov 2007 Archemix Announces Initiation of Phase 2a Trial for Aptamer Product Candidate ARC1779 in Patients with Acute Coronary Syndrome
13 Nov 2007 Introgen and Gendux Submit First Marketing Authorization Application for ADVEXIN
10 Nov 2007 Targeted Genetics Announces Positive Interim Phase I/II Results for tgAAC94 in Inflammatory Arthritis
07 Nov 2007 Sangamo BioSciences Announces ZFP Therapeutic Data From Nerve Regeneration Program at Society for Neuroscience Meeting
07 Nov 2007 Fresenius Medical Care Announces Continued Positive Data from
07 Nov 2007 Data show Geron’s cell-based therapeutic for spinal cord injury survives and exhibits remyelination for at least nine months following injection
06 Nov 2007 Advanced Cell Technology's Chief Scientific Officer Featured Speaker at American College of Rheumatology/ Association of Rheumatology Health Professionals
06 Nov 2007 Sangamo BioSciences Announces Presentation of Phase 1b ZFP Therapeutic Data at Society for Neuroscience Meeting
05 Nov 2007 Sangamo BioSciences Presents Positive Data Showing Pain Reduction by Novel ZFP Therapeutic at Society for Neuroscience Meeting
30 Oct 2007 BioAlliance Pharma's New Entity, AMEP, shows anti-angiogenic and antiproliferative activity in vitro and in vivo
26 Oct 2007 Osiris Therapeutics Initiates Phase II Clinical Trial Evaluating Prochymal(TM) for Type 1 Diabetes
26 Oct 2007 Genzyme and Sunway to Collaborate on Gene Therapy Program in China
24 Oct 2007 Jennerex Presents Clinical Data From JX-594 Demonstrating Tumor Efficacy Against Advanced Liver Cancers
19 Oct 2007 Aastrom Stem Cell Therapy Demonstrates Positive Results in Severe Long Bone Non-Union Fracture Trial
19 Oct 2007 Isis Adds New Drug to Its Development Pipeline: ISIS 388626 Targeting SGLT2 for the Treatment of Type 2 Diabetes
17 Oct 2007 Alnylam and Collaborators Publish New Pre-clinical Results on RNAi Therapeutics for the Treatment of Huntington's Disease
17 Oct 2007 Osiris Therapeutics Receives FDA Clearance to Initiate Phase III Pivotal Trial for Prochymal (TM) as a First Line Treatment for Acute Graft vs. Host Disease
12 Oct 2007 Hemispherx Biopharma Files New Drug Application for Ampligen(R)
09 Oct 2007 Isis Receives $1.25 Million Milestone Payment From iCo for Initiation of Phase 1 Study of iCo-007
08 Oct 2007 Isis Favorably Revises Financial Guidance and Introduces Mipomersen as Generic Name for ISIS 301012
06 Oct 2007 AVONTEC's drug candidate AVT-02 UE for the treatment of inflammatory skin diseases has entered a multiple dosing Phase I study
06 Oct 2007 Isis Reports That ISIS 301012 is Well Tolerated in Patients Treated for Five Or More Months
05 Oct 2007 Aastrom Announces Positive Interim Results From Phase I/II Study Involving Use of Vascular Repair Cells in Patients With Critical Limb Ischemia
04 Oct 2007 Isis Reports Positive Results of Phase 2 Study of ISIS 301012 in Heterozygous FH Patients
03 Oct 2007 Aegera Therapeutics Initiates Four Phase I/II Clinical Trials for AEG35156
02 Oct 2007 Transgene Extends Therapeutic Vaccine Candidate TG4040 Development Program Against Chronic Hepatitis C
25 Sep 2007 Quark Pharmaceuticals Signs Collaboration Agreement With University of Michigan for Development of Proprietary SiRNA Compounds for Noise-Induced Hearing Loss
21 Sep 2007 Vical Licensee Sanofi-aventis Initiates Phase 3 Trial to Reduce Amputations
20 Sep 2007 GenVec Technology Demonstrates Selective Anti-Cancer Activity
19 Sep 2007 VIRxSYS Presents Update on HIV Gene Therapy Clinical Trial at ICAAC
19 Sep 2007 Sangamo BioSciences Presents Data Demonstrating 'In Vivo' Protection Against HIV Infection by CCR5-ZFN Therapeutic
18 Sep 2007 Targeted Genetics Reports on Recombinant DNA Advisory Committee (RAC) Review of its Phase 1/2 Trial of tgAAC94 for Rheumatoid Arthritis
13 Sep 2007 Isis Enters Broad Collaboration With Ortho-McNeil, Inc. for the Discovery, Development and Commercialization of Antisense Drugs to Treat Metabolic Diseases
13 Sep 2007 ATL1102 Phase IIa Multiple Sclerosis Trial Update
06 Sep 2007 MediGene Completes Patient Recruitment for Clinical Trial of Cancer-Killing Virus NV1020
04 Sep 2007 Isis Initiates Phase 1 Study of ISIS 325568 Targeting Glucagon Receptor to Treat Type 2 Diabetes
01 Sep 2007 ATL1103 for Growth & Sight Disorders Project Update
31 Aug 2007 Opko Health Doses First Patient in Phase 3 COBALT Trial of Bevasiranib for the Treatment of AMD
30 Aug 2007 Lorus advances clinical development of GTI-2040 combined with Ara-c in acute myeloid leukemia
29 Aug 2007 Phase II Study of IMC-A12 for Advanced Prostate Cancer Commences Patient Enrollment
29 Aug 2007 Journal of American College of Cardiology Publishes Positive Findings on Generx Now in Phase 3 for Heart Disease
 
<< Start < Prev 1 2 3 4 5 6 7 8 9 10 Next > End >>
Results 151 - 200 of 591

PipelineReview.com is powered by La Merie Business Intelligence La Merie Business Intelligence

For immediate assistance, please call us during business hours: Mon-Fri 09:00am - 18:30pm; GMT+01

La Merie S.L | Passatge Jordi Ferran, 20 | E-08028 Barcelona | T +34 93 342 91 97 | F +34 93 342 91 98 | Email info@lamerie.com | Internet www.lamerie.com
All contents © by La Merie S. L

Competitor Analysis Series

Thrombopoiesis-Stimulating Agents (TPO)

Order Now

Brief Report Series

CD40 and CD40L (CD154) Agonists & Antagonists

Order Now

Subscribe La Merie Biologics